JPMorgan kept its EUR 61 target. Bayer stock gains 1.23 percent

Published on 10/13/2026 at 09:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter sales rose 2.20 percent to EUR 10.87 billion. Bayer stock costs EUR 44.37 on October 13, 2026 versus EUR 43.83.

Key points in brief

JPMorgan maintained its Overweight rating and EUR 61.00 target for Bayer on October 1, 2026.
Bayer reported second-quarter 2026 sales of EUR 10.87 billion, up 2.20 percent year over year.
Bayer stock was trading at EUR 44.37 at Lang & Schwarz on October 13, 2026, 1.23 percent above the Xetra close of October 12, 2026.
Bayer is scheduled to publish its third-quarter results on November 3, 2026.

Pop-Art-Comic-Illustration einer Wissenschaftlerin im Labor und eines Traktors auf einem Feld — Bayer AG (DE000BAY0017): Pop-Art-Comic-Szene mit Laborwissenschaftlerin, Reagenzglas und farbenfroh sprühendem Feld-Traktor im Hintergrund, Illustration mit AI erstellt.

Bayer (ISIN DE000BAY0017) was trading at EUR 44.37 at Lang & Schwarz on October 13, 2026 at 9:08 a.m. CEST, up 1.23 percent versus the Xetra close of October 12, 2026 at EUR 43.83. On October 1, 2026, JPMorgan kept its Overweight rating and EUR 61.00 target, while warning that expectations for the third quarter could be too high, as Boerse Express reported.

Three dates define the setup

On September 24, 2026, Bayer reported second-quarter sales of EUR 10.87 billion, up 2.20 percent year over year, according to Bayer.

On October 1, 2026, JPMorgan maintained the EUR 61.00 target and Overweight rating, with analyst Richard Vosser attributing the third-quarter caution to possible timing shifts in the agricultural business, according to FinanzNachrichten. On October 13, 2026, the Bayer share price stood at EUR 44.37, 1.23 percent above the Xetra close of EUR 43.83.

What does EUR 61 mean?

JPMorgan's target lies 37.48 percent above the Lang & Schwarz price, calculated from EUR 44.37 to EUR 61.00. The comparison gives the analyst view a clear numerical anchor, but the same report identifies agricultural order timing as a near-term uncertainty.

Bayer's latest reported quarter also offers a measurable operating reference. The company said adjusted EBITDA before special items increased 1.90 percent in the second quarter of 2026, while core earnings per share rose 16.70 percent, according to Bayer.

November brings the next test

Bayer has scheduled its third-quarter results, investor video call and media update for November 3, 2026, according to the company's financial calendar. The date places the next formal test of Crop Science demand and full-year expectations less than one month away.

The stock remains below the 52-week high of EUR 53.92 and above the 52-week low of EUR 25.78, both quoted for October 12, 2026. The market capitalization was EUR 43.1 billion on that date.

Bayer stock trades above the Xetra close

At Lang & Schwarz, Bayer stock was trading at EUR 44.37 on October 13, 2026 at 9:08 a.m. CEST, 1.23 percent above the Xetra close of October 12, 2026 at EUR 43.83. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.